Clinical Trial Update: A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD) [Phase 2]

View source ↗

Summary

Phase 2 long-term extension study update for IMVT-1402 in adults with Graves' Disease is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease

Drugs mentioned

• IMVT-1402

Snippet

Sponsor: Immunovant Sciences GmbH | Conditions: Graves' Disease | Phase 2 | Status: ENROLLING_BY_INVITATION